International Clinical Trial: Vision Therapy Combined with Botulinum Toxin Type A Versus Botulinum Toxin Type A Alone for Acute Acquired Comitant Esotropia: A Randomized Controlled Trial

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127043) titled 'Vision Therapy Combined with Botulinum Toxin Type A Versus Botulinum Toxin Type A Alone for Acute Acquired Comitant Esotropia: A Randomized Controlled Trial' on June 23.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Zhongshan Ophthalmic Center,Sun Yat-sen University

Condition: Acute Acquired Comitant Esotropia

Intervention: Control Group:Botulinum toxin type A injection therapy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-25

Target Sample Size: Control Group:20;Experimental Group:20;

Countries of Recruitment: China

To know more, vis...